Rare Nivolumab-associated Super Hyper Progressive Disease in Patients With Advanced Gastric Cancer
Sign Up to like & getrecommendations! Published in 2021 at "In Vivo"
DOI: 10.21873/invivo.12449
Abstract: Background/Aim: Rapid tumor growth after administration of immune checkpoint inhibitors is designated hyper progressive disease (HPD). In this study, besides the conventional HPD category, we proposed the “super HPD” category where the disease is naturally… read more here.
Keywords: advanced gastric; gastric cancer; disease; progressive disease ... See more keywords